Cicada Health Tech Hub Elevate
Enhance your fundamental commercialisation skills with the guidance of industry experts at this exclusive, complimentary 2-day workshop.
This hands-on workshop will guide you through the commercialisation process step-by-step so you walk away with a clear commercial strategy.
Learn proven frameworks, tailored advice, and new ideas on how to articulate your business, engage with customers, and validate the market opportunity.
Who is it for?
Individuals and teams with an idea and want to develop a commercial plan.
Anyone wanting to understand how to assess which ideas have commercial potential and what to do next.
What's involved?
- 4 - 6 hours of online learning
- 2-day in-person workshop
- 3 coaching sessions after the workshop with relevant experts
Important dates.
Date: TBA 2025 (2 day workshop)
Venue: Westmead Health Precinct
Expression of interest open for our 2025 cohort.
Meet your mentors:
Martin Hayes
Founder
MAYES Healthcare
Rebecca Dooley
Senior Associate
Addisons
Silvia Pfeiffer
Founder and Director
Coviu
Katja Beitat
Head of Health Tech
Cicada Innovations
Lilly Bojarski
General Manager
Cicada HealthTech Hub
Harikesh Pushpapathan
Investment Manager, Stoic Venture Capital
Jane Cockburn
PERIscope Program Manager, Sydney Knowledge Hub
Jane designs and delivers programs that build the capacity and capability of our researchers to translate their research impact into practical products and services for our communities and the overall market. This includes evidence-based entrepreneurial frameworks for researchers to understand how their research can meet people’s needs and deliver enduring impact through a variety of partner and business models.
Prashanth Rajan
Brandon Capital
Prashanth was Senior Commercialisation Manager at UniSA Ventures, the commercialisation and investment-management arm of the University of South Australia (UniSA). Prashanth managed a portfolio of IP commercialisation projects and conducted several complex IP transactions. Prashanth was also the Operations Manager for AbRegen, a UniSA Ventures investee company, where he provided strategic leadership to the company and helped secure funding from the EB Research Partnership to further the preclinical program.
Prashanth holds a B. Technology in Bioinformatics from Sathyabama University (India) and a PhD in Biochemistry and Molecular biology, and M. Biotech (Adv) from The University of Queensland.
James Reilly, M.Ed.
CEO of Latent Knowledge
James studied Psychology and Exercise Physiology in undergrad before finishing a Master of Education in Sport Psychology and Coaching from Boston University in 2015. Since then, he has worked at the United States Military Academy at West Point, NY in the Department of Chemistry and Life Science as a Research Scientist focusing on blood biomarkers for osteoarthritis and MTBI, diagnostic methods for infectious disease and Cadet performance, and biomedical devices for regenerative medicine. In 2019, he founded the literature search tool, LitView, and started the knowledge management and research methods company, Latent Knowledge, as the holding company.
Rachel Hooke
Patent & Trademarks Attorney, FB Rice
As a qualified patent attorney, Rachel has over 20 years of experience advising her clients in all matters related to intellectual property. Rachel was recognised in the MIP Top 250 Women in IP Worldwide 2021. She has also been recognised as an IP Star for patent prosecution in Managing Intellectual Property from each year since 2018, and endorsed in the IAM Prosecution recommended list each year since 2019.
From drafting and prosecuting multi-jurisdictional patent families to providing high level strategic advice, clients appreciate Rachel’s experience and ability to see the bigger picture to ensure any IP strategy aligns with their commercial goals.
Rachel is a keen angel investor and a member of the Scale Investors’ network, an organisation that provides early investment support to female-led businesses. Her experience as an investor gives further insights into the pressures and hurdles facing clients when it comes to growing their innovation from an initial idea to a viable business.
Rachel is a registered Australian and New Zealand Patent Attorney.
Dr. Jeremy Kwarcinski
CO-FOUNDER & CEO (iiShield)
Biomedical Engineer
Dr Jeremy Kwarcinski is the co-founder of iiShield, a medical device developer and innovator for the signature KidneyPJ - a single-use, cost-effective medical device that aims to increase the available time for kidney transplantation.
iiShield is one of only three companies to receive funding in 2021 from the NSW Health Medical Devices Fund.
Jeremy is a current resident at the Cicada HealthTech Hub as he and his team continues to develop and refine their product in collaboration with the clinicians and surgeons across the Westmead Health Precinct, in hopes to provide a surgical environment which fosters improved short & long term transplant outcomes.
About Cicada HealthTech Hub
Located inside Westmead Health and Innovation District, The Cicada HealthTech Hub will be a home to early stage health companies, a space for collaboration and commercialisation activation, and a landing pad for industry seeking solutions to their research and business challenges. Helping to contribute to the vision of making Westmead a world-class innovation district in health and education.
